These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 33667419)

  • 21. MiR-15b-5p is Involved in Doxorubicin-Induced Cardiotoxicity via Inhibiting Bmpr1a Signal in H9c2 Cardiomyocyte.
    Wan GX; Cheng L; Qin HL; Zhang YZ; Wang LY; Zhang YG
    Cardiovasc Toxicol; 2019 Jun; 19(3):264-275. PubMed ID: 30535663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HDL protects against doxorubicin-induced cardiotoxicity in a scavenger receptor class B type 1-, PI3K-, and Akt-dependent manner.
    Durham KK; Chathely KM; Mak KC; Momen A; Thomas CT; Zhao YY; MacDonald ME; Curtis JM; Husain M; Trigatti BL
    Am J Physiol Heart Circ Physiol; 2018 Jan; 314(1):H31-H44. PubMed ID: 28986362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adiponectin agonist ADP355 ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and oxidative stress.
    Zhao D; Xue C; Li J; Feng K; Zeng P; Chen Y; Duan Y; Zhang S; Li X; Han J; Yang X
    Biochem Biophys Res Commun; 2020 Dec; 533(3):304-312. PubMed ID: 32958254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trimetazidine ameliorates sunitinib-induced cardiotoxicity in mice via the AMPK/mTOR/autophagy pathway.
    Yang Y; Li N; Chen T; Zhang C; Liu L; Qi Y; Bu P
    Pharm Biol; 2019 Dec; 57(1):625-631. PubMed ID: 31545912
    [No Abstract]   [Full Text] [Related]  

  • 25. Rac1 signalling mediates doxorubicin-induced cardiotoxicity through both reactive oxygen species-dependent and -independent pathways.
    Ma J; Wang Y; Zheng D; Wei M; Xu H; Peng T
    Cardiovasc Res; 2013 Jan; 97(1):77-87. PubMed ID: 23027656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute ethanol exposure-induced autophagy-mediated cardiac injury via activation of the ROS-JNK-Bcl-2 pathway.
    Zhu Z; Huang Y; Lv L; Tao Y; Shao M; Zhao C; Xue M; Sun J; Niu C; Wang Y; Kim S; Cong W; Mao W; Jin L
    J Cell Physiol; 2018 Feb; 233(2):924-935. PubMed ID: 28369910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer Therapies and Cardiomyocyte Viability: Which Drugs are Directly Cardiotoxic?
    Balachandran L; Haw TJ; Leong AJW; Croft AJ; Chen D; Kelly C; Sverdlov AL; Ngo DTM
    Heart Lung Circ; 2024 May; 33(5):747-752. PubMed ID: 38365500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unveiling the Cardiotoxicity Conundrum: Navigating the Seas of Tyrosine Kinase Inhibitor Therapies.
    Ekram J; Rathore A; Avila C; Hussein R; Alomar M
    Cancer Control; 2024; 31():10732748241285755. PubMed ID: 39318033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exogenous spermine ameliorates high glucose-induced cardiomyocytic apoptosis via decreasing reactive oxygen species accumulation through inhibiting p38/JNK and JAK2 pathways.
    He Y; Yang J; Li H; Shao H; Wei C; Wang Y; Li M; Xu C
    Int J Clin Exp Pathol; 2015; 8(12):15537-49. PubMed ID: 26884823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imatinib‑ and ponatinib‑mediated cardiotoxicity in zebrafish embryos and H9c2 cardiomyoblasts.
    Zakaria ZZ; Suleiman M; Benslimane FM; Al-Badr M; Sivaraman S; Korashy HM; Ahmad F; Uddin S; Mraiche F; Yalcin HC
    Mol Med Rep; 2024 Oct; 30(4):. PubMed ID: 39219269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Upregulation of phosphoinositide 3-kinase prevents sunitinib-induced cardiotoxicity in vitro and in vivo.
    Li C; Zou R; Zhang H; Wang Y; Qiu B; Qiu S; Wang W; Xu Y
    Arch Toxicol; 2019 Jun; 93(6):1697-1712. PubMed ID: 31025080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulated cell death pathways in doxorubicin-induced cardiotoxicity.
    Christidi E; Brunham LR
    Cell Death Dis; 2021 Apr; 12(4):339. PubMed ID: 33795647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EGFR Inhibitor Gefitinib Induces Cardiotoxicity through the Modulation of Cardiac PTEN/Akt/FoxO3a Pathway and Reactive Metabolites Formation:
    Alhoshani A; Alanazi FE; Alotaibi MR; Attwa MW; Kadi AA; Aldhfyan A; Akhtar S; Hourani S; Agouni A; Zeidan A; Korashy HM
    Chem Res Toxicol; 2020 Jul; 33(7):1719-1728. PubMed ID: 32370496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The protective effect of losartan against sorafenib induced cardiotoxicity: Ex-vivo isolated heart and metabolites profiling studies in rat.
    Abdelgalil AA; Mohamed OY; Ahamad SR; Al-Jenoobi FI
    Eur J Pharmacol; 2020 Sep; 882():173229. PubMed ID: 32505666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ferroptosis inhibitor alleviates sorafenib-induced cardiotoxicity by attenuating KLF11-mediated FSP1-dependent ferroptosis.
    Li Y; Yan J; Sun H; Liang Y; Zhao Q; Yu S; Zhang Y
    Int J Biol Sci; 2024; 20(7):2622-2639. PubMed ID: 38725840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Time course of changes in oxidative stress and stress-induced proteins in cardiomyocytes exposed to doxorubicin and prevention by vitamin C.
    Ludke A; Akolkar G; Ayyappan P; Sharma AK; Singal PK
    PLoS One; 2017; 12(7):e0179452. PubMed ID: 28678856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Over-expression of calpastatin aggravates cardiotoxicity induced by doxorubicin.
    Wang Y; Zheng D; Wei M; Ma J; Yu Y; Chen R; Lacefield JC; Xu H; Peng T
    Cardiovasc Res; 2013 Jun; 98(3):381-90. PubMed ID: 23455548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sorafenib cardiotoxicity increases mortality after myocardial infarction.
    Duran JM; Makarewich CA; Trappanese D; Gross P; Husain S; Dunn J; Lal H; Sharp TE; Starosta T; Vagnozzi RJ; Berretta RM; Barbe M; Yu D; Gao E; Kubo H; Force T; Houser SR
    Circ Res; 2014 May; 114(11):1700-1712. PubMed ID: 24718482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Astragaloside IV inhibits doxorubicin-induced cardiomyocyte apoptosis mediated by mitochondrial apoptotic pathway via activating the PI3K/Akt pathway.
    Jia Y; Zuo D; Li Z; Liu H; Dai Z; Cai J; Pang L; Wu Y
    Chem Pharm Bull (Tokyo); 2014; 62(1):45-53. PubMed ID: 24390491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CIRBP-OGFR axis safeguards against cardiomyocyte apoptosis and cardiotoxicity induced by chemotherapy.
    Liu C; Cheng X; Xing J; Li J; Li Z; Jian D; Wang Y; Wang S; Li R; Zhang W; Shao D; Ma X; Chen X; Shen J; Shi C; Guo Z; Wang W; Fan T; Liu L; Tang H
    Int J Biol Sci; 2022; 18(7):2882-2897. PubMed ID: 35541895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.